Patheon Pharmaceuticals

Established in 1923, Diosynth Biotechnology operates a manufacturing plant that utilizes cell culture and microbial production processes to manufacture drugs. The company offers a range of recombinant therapeutic proteins and vaccines for preclinical, clinical and commercial purposes. Its analytical development team works on various techniques, such as DNA sequencing, biophysical characterization, capillary electrophoresis and mass spectrometry. Diosynth Biotechnology manufactures products using mammalian, insect and microbial expression systems. In addition, the company s cell culture development technology utilizes hybridomas, murine myelomas and human cell lines. It undertakes real time stability studies for products, intermediates and reference standards. Diosynth Biotechnology maintains a location in Morrisville, N.C.

Located in Morrisville, NC, Catalent Pharma Solutions is a cutting-edge pharmaceutical lab dedicated to innovation and excellence. With state-of-the-art equipment and a team of skilled professionals, this facility plays a crucial role in advancing healthcare solutions and improving patient outcomes. From drug development to manufacturing, Catalent Pharma Solutions is at the forefront of the industry, conducting groundbreaking research and ensuring the highest quality standards are met. As a hub of scientific discovery and technological advancement, this facility embodies a commitment to pushing the boundaries of pharmaceutical innovation, making it a key player in shaping the future of healthcare. Generated using this place's available information

Founded in 2002, Chimerix is a privately held biotechnology company that creates and develops orally available medicines from bioactive molecules. Its applications of proprietary technology enhance oral availability, stabilize drug in plasma and facilitates the delivery of drugs into targeted tissues. Chimerix offers drugs that can be modified to improve dosing parameters, broaden therapeutic applications and decrease the risk of adverse reactions. Its technology also enables discovery of new drugs from molecules with chemical properties that would otherwise be unsuitable for pharmaceutical development. In addition, Chimerix applies its technology towards discovery and the development of oral drugs for the treatment of smallpox, drug-resistant HIV infection and viral hepatitis. The company is located in Durham, N.C.